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Sustainable clinical laboratory capacity for health in Africa
The 2008 Maputo Declaration on Strengthening of 
Laboratory Systems and the subsequent 2012 African 
Society for Laboratory Medicine Ministerial Call for 
Action1 drew attention to the importance of laboratory 
services. Most recently, laboratories have gained 
prominence in the accurate detection of infectious 
diseases—including emerging public health threats—
and monitoring of antimicrobial drug resistance, 
especially within the context of the Global Health 
Security Agenda. Equally important, but relatively 
marginalised, is the role of laboratories in dealing with 
all diseases, in ensuring quality clinical care towards 
universal health coverage (UHC), and meeting the 
targets of Sustainable Development Goal 3. 
At the African Society for Laboratory Medicine meeting 
in Cape Town, South Africa, in December, 2016, we met 
to discuss the state of laboratory services in the light of 
Africa’s burden of both communicable diseases and non-
communicable diseases. We highlighted gaps in coverage, 
quality, human resources, infrastructure, access, and 
sustainability, and discussed how these gaps could be 
bridged in an economically viable manner. We summarise 
our discussions and key messages (panel) here.
The coverage and quality of laboratory services 
throughout Africa is inadequately documented. Quality 
provided by individual laboratories is questioned,2 and 
not all facilities are enrolled in external quality assurance 
schemes. For example, in 2013, an evaluation of 
accredited laboratories in sub-Saharan Africa indicated 
that 37 of 49 countries had no medical laboratories 
that met internationally recognised quality standards.3 
However, the WHO/AFRO Laboratory Improvement 
Process Towards Accreditation4 has been expanded 
rapidly in many countries in Africa over the past 5 years, 
with promising initial results. 
High-quality services are largely dependent on 
appropriately trained and qualiﬁ ed laboratory personnel, 
yet laboratory professionals continue to ﬁ gure 
prominently among neglected health cadres across sub-
Saharan Africa.5,6 There are often insuﬃ  cient numbers, 
a skewed distribution, low level of qualiﬁ cations, and 
limited career opportunities. Personnel often work in 
poorly equipped facilities, and do not systematically 
respect safety standards. Some organisations have 
developed training initiatives (eg, Amref7), but 
investment in developing professionals needs to 
increase via formal education, continuing professional 
development, and peer-to-peer learning initiatives. More 
attention should also be paid to training multiskilled 
professionals capable of working in laboratories 
equipped to deal with a broad range of health conditions, 
not just individual communicable diseases. 
There is a movement towards broadening infrastructure 
for non-communicable diseases8 and in integration.9–11 
But entrenched thinking in terms of the need for 
specialisation still needs to be overcome. Similarly, tension 
exists between developing centralised laboratories 
with broad-based services and providing the point-of-
care testing necessary for patient-centred care. Where 
the balance lies will depend on factors such as the 
distribution and disease mix of the population, availability 
of transport, information technology, and other 
sociocultural and health educational factors. Ultimately, 
with the development of rapid transport links and good 
information technology structures, the necessity of 
proximate-to-patient services may decline. However, 
until such infrastructure is widely accessible, the question 
that should be asked is what other tests can be done at 
decentralised facilities? 
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Panel: Key messages
• Clinical service laboratories should be recognised as 
having a key role in deﬁ ning the health-care needs of 
populations
• Economic indicators of eﬃ  ciency and ﬁ nancial 
sustainability are needed to ensure uninterrupted 
provision of high-quality laboratory services
• Quality, multiplatform, timely, patient-focused laboratory 
services should be included in UHC packages
• The rollout of technologies that increase the speed and 
accuracy of diagnosis of multiple conditions should be 
considered and strategies for strengthening the 
clinician–laboratory worker interface should be 
introduced to bolster uptake
• Each country should create a roadmap for laboratory 
development with well-deﬁ ned targets for distribution, 
providers (public or private), breadth of tests covered, 
quality improvement and training, and ﬁ nances. They 
should propose innovative strategies for ensuring greater 
autonomy, accountability, and sustainability
• Research capacity strengthening of laboratories is critical to 
ensuring sustainability of laboratories and the development 
of the best technologies for use in individual settings
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As well as geographical access barriers, aﬀ ordability 
of laboratory tests in terms of direct and indirect costs 
that result in high out-of-pocket payments likely 
remains a key obstacle to access and meeting UHC 
targets.12 Economic considerations are also essential to 
sustainability. Economics informs which tests should 
be prioritised; deﬁ nes where there are eﬃ  ciency gains 
and tradeoﬀ s; measures eﬃ  ciency gains of adopting 
new technologies; and can evaluate the economic 
case for integration of services. Additionally, there is a 
need for a frank and open discussion about the use of 
public or private laboratories to achieve UHC, keeping 
in mind that private providers may be able to provide 
services that public providers cannot. They can also oﬀ er 
opportunities for transferring risks to the private sector 
through equipment leasing13 as well as for training and 
development of personnel in the public sector. 
The economic viability of laboratories also hinges 
on allowing facilities greater autonomy and ﬂ exibility. 
Currently, laboratories are often passive recipients 
of personnel, equipment, and reagents. Initiatives 
giving laboratories greater ability to generate and 
retain funds have led to promising results and should 
be given greater attention. Likewise, performance-
based ﬁ nancing could help to drive eﬃ  ciency gains and 
may trigger a more rapid improvement in the quality 
improvement process towards accreditation.14 Greater 
attention also needs to be devoted to developing the 
research activities of laboratories—such as for clinical 
trials and product development—which could be useful 
sources of revenue. Active involvement of laboratory 
personnel in research projects is also beneﬁ cial in 
providing contextual information needed for the uptake 
of novel diagnostic technologies. 
Recurring keywords from our meeting were quality, 
integration, patient focus, sustainability, and autonomy. 
Whilst recognising that there is now broad-based, albeit 
sotto-voce, recognition that laboratory services are 
essential to health systems globally, more systematic 
attention should be paid to the issues described in this 
Comment for their value to be truly realised. 
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